CN1037323C - Therapeutic instrument for myopia and amblyopia - Google Patents

Therapeutic instrument for myopia and amblyopia Download PDF

Info

Publication number
CN1037323C
CN1037323C CN93100828A CN93100828A CN1037323C CN 1037323 C CN1037323 C CN 1037323C CN 93100828 A CN93100828 A CN 93100828A CN 93100828 A CN93100828 A CN 93100828A CN 1037323 C CN1037323 C CN 1037323C
Authority
CN
China
Prior art keywords
auricle
sensitive spot
eyes
catalyst
myopia
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
CN93100828A
Other languages
Chinese (zh)
Other versions
CN1089173A (en
Inventor
李兰舫
何柏乾
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Individual
Original Assignee
Individual
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Individual filed Critical Individual
Priority to CN93100828A priority Critical patent/CN1037323C/en
Publication of CN1089173A publication Critical patent/CN1089173A/en
Application granted granted Critical
Publication of CN1037323C publication Critical patent/CN1037323C/en
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Images

Landscapes

  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention relates to an instrument for treating myopia and amblyopia, which is composed of a treatment program controller, a sensitive spot contactor for auricle and eye periphery, etc. The present invention combines medical ear acupuncture medicine and eye acupuncture medicine in China with modern electronic medicine, and solves the problem of the placement of 10 to 18 pairs of eye peripheral sensitive spots, 4 to 5 pairs of auricle's sensitive spots and electrodes. The present invention is an instrument for treating myopia and amblyopia, which integrates integrated treatment with local treatment. By clinical application, the present invention treats various kinds of myopia for 1 treating course (10 days), and treats various kinds of amblyopia for 3 treating courses (30 days), and the effective rate is about 99%. Various kinds of myopia are treated for 30 min for the first time, and the eyesight can be enhanced by 1 to 3 rows. The instrument has the advantages of simple structure, low cost and programming operation, and is suitable for patients' families.

Description

Vision enhancer
The present invention relates to medical apparatus and instruments, specifically be meant the vision enhancer of curing low vision disease,
Over year, according to height not down, particularly myopia accounts for pupil's 30~50%, accounts for middle school student's 50~80% always for the myopia among the primary and secondary students, amblyopia sickness rate surplus in the of nearly ten.Student, the head of a family, educational circles have been become so that the common problem of paying close attention to of the whole society.It also is the problem that domestic and international medical circle is felt the sour jujube thing jointly.In recent years, though medical circle has been released bathomorphic method of many treatments and instrument both at home and abroad, as: magnetic therapy, acupuncture treatment, ear acupuncture and ear are pressed treatment, acupoint massage, photoelectricity treatment, and unidirectional current irritates and medicine ion penetration to treat, Chinese medicine and western medicine eye drip and operation on cornea radiation incision etc.These treatments have certain curative effect to myopia, but because the former acupoint selection very little, and is difficult for getting standard, still all single emphasis topical therapeutic.Because human body is a unified integral body, ignore the adjustment of allomeric function, partial curative effect can be not fine, and the many genus of effect are of short duration.Former Soviet Union initiative, at present domestic cornea radiation of having introduced is cut and is controlled nearly art, the operating difficulty height, patient's misery has a big risk, and charge is expensive, and most of patients dare not be accepted.
And for example (application number: 921001541 publication numbers: CN1065392A), this instrument mainly adopts this method of unidirectional current drug iontophoresis mainly to act near the eyes to the broad pulse DC instrument for treatment of myopia, utilizes medicinal liquid to apply unidirectional current and imports the ruling by law treatment.Because whole eyelet all has galvanic effect, has influenced special the irritating of acupuncture point (sensitive spot), ignored the function that ear acupuncture is regulated the whole machine body internal organs, so its certain curative effect is also just well imagined.And this instrumentation is more loaded down with trivial details.Join dropping liquid and be difficult for grasping, can not enter huge numbers of families and grasp use for the patient.
The present invention is the internal organs according to motherland's medical science---ear and eye in the theory of channels and collaterals, ear and internal organs, the theory of eye and the specific internal relation of internal organs, the principle of curing the disease with " pin ", " ear acupuncture " combines and the vision enhancer of the novelty that development and design becomes with hyundai electronics medical science.The present invention improves on my initiative " ear and sensitive spot pressing treatment near the eyes " basis, development is succeeded in developing." ear acupoint adds sensitive spot pressing near the eyes treatment juvenile myopia 4134 routine efficacy analysis " literary composition that I write once was published in " the international ear treatment academic discussion " held in Beijing in 1989.(seeing Appendix)
The objective of the invention is according to motherland's medical science internal organs and theory of channels and collaterals allomeric function adjustment and topical therapeutic to be combined at a kind of vision enhancer of development.This instrument has solved the placement of 4~5 pairs of auricle sensitive spots and electrode thereof, is intended to balance and adjusts the internal organs function of myope's imbalance.10~18 pairs have been solved to the placement of sensitive spot and electrode thereof near the eyes, be intended to promote the QI-blood circulation of eyeball and tissue thereof, the convulsion that reaches meridians dredging, activating blood and removing stasis, eliminating stagnation spasmolytic, releasing ciliary muscle is twin, promote retina, the QI and blood of optic cell, nutrition supply, enhance metabolism, and then its function is rehabilitated and strengthen.For overcoming complex operation that existing therapeutic instrument exists, using shortcoming such as inconvenience.The present invention adopts the programme-control of therapeutic process, and can be automatically and dual-use manual, is convenient to the patient and grasps treatment voluntarily.For entering huge numbers of families, this therapeutic instrument created condition.
The objective of the invention is to realize by following manner: vision enhancer is by controlling cyclelog 1, sensitive spot catalyst 16 and auricle sensitive spot catalyst 28 near the eyes, and sensitive spot electrode contact 17, auricle sensitive spot electrode contact 30 are formed near the eyes; Reaching auricle sensitive spot electrode near the eyes is set in respectively in the slidable adjustment groove 19 and 27 on the gill sensitive spot catalyst near the eyes; Sensitive spot electrode contact in gill corridor all has elastic telescopic near the eyes, and the contact surface of contact skin studs with conductive rubber; Reaching auricle sensitive spot catalyst frame 16,28 near the eyes all adopts printed circuit board (PCB) to make each sensitive spot electrode follow procedure arrangement thereon; Be connected with treatment procedure controller 1 with two core plugs 32 by multi-pin connector 22 respectively with auricle sensitive spot catalyst near the eyes.
The drawing of accompanying drawing is described as follows:
Fig. 1 is a treatment procedure controller profile sketch map
Fig. 2 is sensitive spot catalyst near the eyes
Fig. 3 is an auricle sensitive spot catalyst
Fig. 4 is sensitive spot position view near the eyes
Fig. 5 is an auricle sensitive spot position view
Fig. 6 is a therapeutic instrument electricity theory diagram
The present invention will be further described accompanying drawing in conjunction with the embodiments.
With reference to Fig. 1, Fig. 6: be the profile sketch map and the electrical schematic diagram of treatment procedure controller.But impulse waveform is regulated turn impulse waveform selector switch 5; But pulse frequency is regulated turn output frequency actuator 1,8; But output amplitude is regulated turn output amplitude by-pass cock 10,11; But treatment procedure is regulated turn treatment procedure by-pass cock 3; But pulse polarity conversion turn polarity reversing switch 12.Treatment procedure " manually " or " automatically " can be stirred program control switch 6.
With reference to Fig. 1, Fig. 2, Fig. 3: multi-pin connector 22 and two core plugs 32 insert the porous socket 7 and the tip jack 9 of treatment procedure controller respectively, realize near the eyes, auricle sensitive spot catalyst is connected with the treatment procedure controller.
Being connected and fixed of sensitive spot catalyst is with 15 near the eyes, can be by cloth, skin, adhesive tape, mould materials such as band, elastic cord and make, there is velcro 24 at two ends, as sensitive spot catalyst and patient near the eyes after sensitive spot coincide near the eyes, with the velcro at connecting band two ends rear pillow part join realize fixing.
The spring leaf 26 of auricle sensitive spot catalyst and support 25 have elasticity and flexibly connect.Auricle sensitive spot catalyst 28 is connected with support by fixed screw 31.Like this, the responsive catalyst of auricle can adapt to of all sizes, different capitiform.
With reference to Fig. 2, Fig. 3, Fig. 4, Fig. 5: near the eyes, the therapeutic electrode contact 17,30 of auricle sensitive spot catalyst is set in slidable adjustment groove 19 and 27 respectively, can be with patient's eye socket and the different slidable adjustment of doing of auricle.The contact surface of electrode contact and skin is a conductive rubber, has elastic telescopic, and it is uneven only to manage patient's face, and electrode contact can be close to skin all the time.
Sensitive spot 10~18 is to (33~50) near the eyes, all around eye socket (with the eye socket mid point is the center, radially distributes).
Auricle sensitive spot 4~5 is to (51~55), divide center 52 at triangular fossa, crus of helix mid point under 53, in the intertragic notch 54, the center 55 of ear-lobe, the front lower place 51 of intertragic notch.
With reference to Fig. 6 is the electrical schematic diagram of therapeutic instrument: electric current produces the various impulse waves of setting by little electric pulse generation circuit, through the treatment procedure device of setting, by outlet line little electric pulse is reached auricle again, the sensitive spot catalyst acts on human body then near the eyes.The frequency of pulse, waveform, output amplitude and pulse polarity can be regulated by device separately.
Above-mentioned 18 pairs and 5 pairs of sensitive spots, all near, the amblyopia patient of example visits the side screening and decides surplus clinical 5000.
I make the treatment group in clinical practice the present invention, and with auricle, the sensitive spot pressing compares respectively 30 examples of group treatment juvenile myopia near the eyes, its result is as follows:
Case and physical data;
The treatment group: 30 examples are totally 60 eyes, male 18 examples, women 12 examples; 7~21 years old age, vision 0.1~0.8 before controlling; The course of disease 1~8 year.
Matched group: 30 examples are totally 59 eyes, male 16 examples, women 14 examples; 6~19 years old age, vision 0.1~0.8 before controlling.The course of disease 1~7 year.
The method and the course of treatment:
Two groups are all adopted every day 1 time, and 10 times was 1 course of treatment.
Table one
Vision contrast table before two group of 60 example controlled
Eye is looked several power groups 0.1 0.12 0.15 0.2 0.25 0.3 0.4 0.5 0.6 0.8
Treatment group (30 people) 6 7 4 5 7 6 10 12 2 1
Matched group (30 people) 5 7 5 5 6 5 9 13 2 2
Through controlling 10 days (course of treatment): the treatment group: cure rate is 30%, and obvious effective rate is 48.3% total effective rate 99%; Matched group: cure rate is 16.9%, and obvious effective rate is 25.4%, total effective rate 97%.(seeing table two for details)
Table two: two groups of therapeutic effect contrast tables (in the parantheses is efficient)
Several numbers of group example are cured the produce effects enabledisable
Treatment organizes 30 60 18 (30%) 29 (48.3%) 12 (20%) 1 (1.6%)
Matched group 30 59 10 (16.9%) 15 (25.4%) 30 (50.8%) 4 (6.7%)
Learn by statistics and handle: there is the meaning of highly significant (Ridit analytic process) U=3.516 P<0.01.
With this therapeutic instrument treatment children with amblyopia 5 examples, 10 eyes, wherein: male 2 examples, women 3 examples, 5~9 years old age.Vision sees Table three before controlling.
Vision situation before 10 amblyopia eye treatments of table three
Vision 0.1 0.15 0.25 0.4 0.5 adds up to
Eye several 23113 10
Therapeutic Method: every day 1 time, each 30 minutes, 30 times was 1 course of treatment.
Curative effect: 10 eyes, through controlling 1 course of treatment (30 days), every on average has a net increase of vision is 0.429 effectively to be 100% (seeing table four for details)
10 amblyopia eye treatments of table four vision improves situation
Vision 0.1 0.1 0.15 0.15 0.15 0.25 0.4 0.5 0.5 0.5 before controlling
Control back vision 0.3 0.4 0.4 0.5 0.6 0.6 0.8 1.0 1.2 1.2

Claims (4)

1. vision enhancer is by treatment procedure controller (1), sensor (16), auricle sensitive spot catalyst (28) are formed near the eyes, it is characterized in that: reach near the eyes that auricle sensitive spot electrode is set in respectively near the eyes, in the slidable adjustment groove (19) and (27) on the auricle sensitive spot catalyst, near the eyes, auricle sensitive spot electrode contact all has elastic telescopic; The contact surface of contact skin studs with conductive rubber; Reach auricle sensitive spot catalyst (16) (28) near the eyes, all adopt printed circuit board (PCB) to make, each sensitive spot electrode is arranged thereon in order
2. vision enhancer according to claim 1, it is characterized in that sensitive spot catalyst (16) is provided with the 10-18 counter electrode near the eyes, the 10-18 counter electrode is set in respectively in the slidable adjustment groove (19) on the sensitive spot catalyst near the eyes, and slidable adjustment groove (19) is to be that the center radially distributes with the eye socket mid point
3. according to the vision enhancer that claim 1 connected, it is characterized in that auricle sensitive spot catalyst (28) is provided with the 4-5 counter electrode, the 4-5 counter electrode is set in respectively in the slidable adjustment groove (27) on the auricle sensitive spot catalyst.
4. vision enhancer according to claim 1 is characterized in that auricle sensitive spot catalyst (28) is to take by stainless steel spring sheet (26) and plastic stent (25), the head hoop shape device that catalyst that printed circuit is made (28) and therapeutic electrode (30) are formed.
CN93100828A 1993-01-06 1993-01-06 Therapeutic instrument for myopia and amblyopia Expired - Fee Related CN1037323C (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN93100828A CN1037323C (en) 1993-01-06 1993-01-06 Therapeutic instrument for myopia and amblyopia

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN93100828A CN1037323C (en) 1993-01-06 1993-01-06 Therapeutic instrument for myopia and amblyopia

Publications (2)

Publication Number Publication Date
CN1089173A CN1089173A (en) 1994-07-13
CN1037323C true CN1037323C (en) 1998-02-11

Family

ID=4983252

Family Applications (1)

Application Number Title Priority Date Filing Date
CN93100828A Expired - Fee Related CN1037323C (en) 1993-01-06 1993-01-06 Therapeutic instrument for myopia and amblyopia

Country Status (1)

Country Link
CN (1) CN1037323C (en)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN103977502A (en) * 2014-04-24 2014-08-13 辽宁中医药大学附属医院 Electric pulse eye acupuncture therapeutic equipment

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2057105U (en) * 1989-11-09 1990-05-16 沈丽霞 Therapeutic apparatus for myopia
CN1053750A (en) * 1991-03-09 1991-08-14 王兰芳 Music instrument for preventing and curing myopia
CN1068509A (en) * 1992-06-06 1993-02-03 吴振耀 Nearsight therapeutic apparatus with introducing

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN2057105U (en) * 1989-11-09 1990-05-16 沈丽霞 Therapeutic apparatus for myopia
CN1053750A (en) * 1991-03-09 1991-08-14 王兰芳 Music instrument for preventing and curing myopia
CN1068509A (en) * 1992-06-06 1993-02-03 吴振耀 Nearsight therapeutic apparatus with introducing

Also Published As

Publication number Publication date
CN1089173A (en) 1994-07-13

Similar Documents

Publication Publication Date Title
CN101184524A (en) Micro-dermal tone skin stimulator
Zhang et al. Role of parameter setting in electroacupuncture: current scenario and future prospects
CN1095385C (en) Multifunctional bionic electrotherapeutic apparatus
CN201211318Y (en) Human machine incorporation electric manual massaging device
CN1037323C (en) Therapeutic instrument for myopia and amblyopia
CN201529321U (en) Insomnia therapeutic apparatus
CN1065392A (en) Wide pulse type dc instrument for treatment of myopia
CN216629424U (en) Wearable percutaneous nerve electrical stimulation migraine therapeutic instrument
CN106237511A (en) A kind of meridians electrotherapeutic apparatus
RU2264234C1 (en) Method for craniospinal electromagnet therapy and device for its realization
CN110960797A (en) Pulse electromagnetic field whole body treatment device
CN1046086C (en) Comprehensive therapeutic instrument for myopia and astigmatism of teenagers
CN212067460U (en) Low-frequency pulse moxibustion device
CN210785378U (en) Amblyopia physiotherapy rehabilitation device for ophthalmology
CN201744075U (en) Instrument for treating myopia and amblyopia
CN212090518U (en) Special release appearance of painful switch
CN217015083U (en) Biological feedback type accurate electrical stimulation and curative effect evaluation device
CN219149008U (en) Music transcranial electric stimulation device
CN2693274Y (en) Frequency and pressure adjustable pulse therapeutic device
CN202761914U (en) Anti-fatigue driving instrument
CN202605533U (en) Myopia therapeutic instrument possessing voice identification and frequency modulation functions
CN201168340Y (en) Therapeutic equipment for treating high blood sugar, high blood pressure and high blood fat
CN213100434U (en) Encephalopathy therapeutic equipment
CN2065489U (en) Electrotherapeutic instrument for pseudomyopia
CN207084965U (en) Channels and collaterals cell health-preserving instrument

Legal Events

Date Code Title Description
C06 Publication
PB01 Publication
C10 Entry into substantive examination
SE01 Entry into force of request for substantive examination
C14 Grant of patent or utility model
GR01 Patent grant
C19 Lapse of patent right due to non-payment of the annual fee
CF01 Termination of patent right due to non-payment of annual fee